Evidence map›Paper›PMID 29784664›Full record

ReviewDisease models & mechanisms2018

A guide to using functional magnetic resonance imaging to study Alzheimer's disease in animal models.

Mazen Asaad, Jin Hyung Lee

Open access · goldAbstract readReview
In one paragraph

Review in Disease models & mechanisms, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Application of Optogenetics in Neurodegenerative Diseases.Cellular and molecular neurobiology · 2024
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Main Alkaloids inInternational journal of molecular sciences · 2021
    Article
  9. Therapeutic Mechanism and Key Alkaloids ofFrontiers in pharmacology · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Disease modelling in human organoids.Disease models & mechanisms · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Mazen AsaadDepartment of Neurology and Neurological Sciences, Stanford University, Stanford, CA 94305, USA.
Jin Hyung LeeDepartment of Neurology and Neurological Sciences, Stanford University, Stanford, CA 94305, USA ljinhy@stanford.edu.ORCID 0000-0002-4190-0967
Stanford University · US

Funding

Dynamic regulation of whole brain circuit function by basal ganglia pathwaysR01NS091461 · NINDS · STANFORD UNIVERSITY · PI LEE, JIN HYUNG · 2015 to 2019
$2.4M
Deconstructing Arousal Regulation Circuits for Optimal DBS Therapy DesignR01NS087159 · NINDS · STANFORD UNIVERSITY · PI LEE, JIN HYUNG · 2014 to 2018
$1.9M
Direct Visualization of Cell-Type Specific AD Networks for Drug DevelopmentRF1AG047666 · NIA · STANFORD UNIVERSITY · PI LEE, JIN HYUNG · 2014 to 2014
$1.8M
NIA NIH HHS RF1 AG047666NINDS NIH HHS R01 NS087159NINDS NIH HHS R01 NS091461
6 · The paper itself

Abstract

Alzheimer's disease is a leading healthcare challenge facing our society today. Functional magnetic resonance imaging (fMRI) of the brain has played an important role in our efforts to understand how Alzheimer's disease alters brain function. Using fMRI in animal models of Alzheimer's disease has the potential to provide us with a more comprehensive understanding of the observations made in human clinical fMRI studies. However, using fMRI in animal models of Alzheimer's disease presents some unique challenges. Here, we highlight some of these challenges and discuss potential solutions for researchers interested in performing fMRI in animal models. First, we briefly summarize our current understanding of Alzheimer's disease from a mechanistic standpoint. We then overview the wide array of animal models available for studying this disease and how to choose the most appropriate model to study, depending on which aspects of the condition researchers seek to investigate. Finally, we discuss the contributions of fMRI to our understanding of Alzheimer's disease and the issues to consider when designing fMRI studies for animal models, such as differences in brain activity based on anesthetic choice and ways to interrogate more specific questions in rodents beyond those that can be addressed in humans. The goal of this article is to provide information on the utility of fMRI, and approaches to consider when using fMRI, for studies of Alzheimer's disease in animal models.

Indexed as

Magnetic Resonance ImagingAlzheimer DiseaseAnesthesiaAnimalsConfounding Factors, EpidemiologicDisease Models, AnimalHumansOptogeneticsAlzheimer's diseaseAnesthesiafMRIMouse modelsResting state

Identifiers

PMID29784664
PMCPMC5992611
OpenAlexW2804318715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.